JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HPR
3501
DELISTED
HighPoint Resources Corporation
HPR
| $1.32M | ﹤0.01% |
15,628
-5,169
| -25% | -$337K |
|
|
FLNT
3502
Fluent
FLNT
$132M
| $1.32M | ﹤0.01% |
87,938
-46,113
| -34% | -$622K |
|
3503
Lifetime Brands
LCUT
$220M
| $1.32M | ﹤0.01% |
189,529
-21,306
| -10% | -$153K |
|
3504
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.27B
| $1.32M | ﹤0.01% |
49,752
+38,773
| +353% | +$1.03M |
|
|
AFI
3505
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.31M | ﹤0.01% |
307,846
-131,197
| -30% | -$642K |
|
|
PNNT
3506
Pennant Park Investment Corp
PNNT
$249M
| $1.31M | ﹤0.01% |
201,214
-1,599,076
| -89% | -$9.94M |
|
3507
Winmark
WINA
$1.26B
| $1.31M | ﹤0.01% |
6,628
+3,294
| +99% | +$594K |
|
3508
McGrath RentCorp
MGRC
$2.94B
| $1.31M | ﹤0.01% |
17,153
+1,309
| +8% | +$95K |
|
|
AMNB
3509
DELISTED
American National Bankshares Inc
AMNB
| $1.31M | ﹤0.01% |
33,139
+12,361
| +59% | +$460K |
|
3510
PUT
CF Industries
CF
$17.7B
| $1.31M | ﹤0.01% |
27,400
| – | – |
|
3511
Northrim BanCorp
NRIM
$601M
| $1.31M | ﹤0.01% |
136,424
+12,296
| +10% | +$118K |
|
|
TBCH
3512
PUT
Turtle Beach Corp
TBCH
$230M
| $1.31M | ﹤0.01% |
138,200
+35,700
| +35% | +$350K |
|
|
PTR
3513
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $1.3M | ﹤0.01% |
25,936
| – | – |
|
3514
Precision BioSciences
DTIL
$201M
| $1.3M | ﹤0.01% |
3,130
+3,030
| +3,030% | +$952K |
|
3515
Forrester Research
FORR
$224M
| $1.3M | ﹤0.01% |
31,243
-25,374
| -45% | -$946K |
|
3516
Pathward Financial
CASH
$1.79B
| $1.3M | ﹤0.01% |
35,551
-28,847
| -45% | -$982K |
|
|
FRTA
3517
DELISTED
Forterra, Inc
FRTA
| $1.29M | ﹤0.01% |
111,679
+65,151
| +140% | +$634K |
|
3518
Farmers National Banc Corp
FMNB
$970M
| $1.29M | ﹤0.01% |
78,909
+1,613
| +2% | +$24.6K |
|
3519
Assured Guaranty
AGO
$3.35B
| $1.28M | ﹤0.01% |
26,150
-12,117
| -32% | -$579K |
|
3520
Spero Therapeutics
SPRO
$71.8M
| $1.28M | ﹤0.01% |
133,278
-33,448
| -20% | -$361K |
|
|
CHS
3521
DELISTED
Chicos FAS, Inc.
CHS
| $1.28M | ﹤0.01% |
335,395
-14,985
| -4% | -$57.6K |
|
3522
CALL
Macy's
M
$6.27B
| $1.27M | ﹤0.01% |
+75,000
| New | +$1.17M |
|
3523
argenx
ARGX
$53.6B
| $1.27M | ﹤0.01% |
7,939
-24,483
| -76% | -$3.31M |
|
3524
Badger Meter
BMI
$3.78B
| $1.27M | ﹤0.01% |
19,620
-28,546
| -59% | -$1.69M |
|
3525
IDT Corp
IDT
$1.67B
| $1.27M | ﹤0.01% |
176,186
+145,644
| +477% | +$1.05M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.